| pubmed-article:9051394 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9051394 | lifeskim:mentions | umls-concept:C0011860 | lld:lifeskim |
| pubmed-article:9051394 | lifeskim:mentions | umls-concept:C0271650 | lld:lifeskim |
| pubmed-article:9051394 | lifeskim:mentions | umls-concept:C0017725 | lld:lifeskim |
| pubmed-article:9051394 | lifeskim:mentions | umls-concept:C0920563 | lld:lifeskim |
| pubmed-article:9051394 | lifeskim:mentions | umls-concept:C1256369 | lld:lifeskim |
| pubmed-article:9051394 | lifeskim:mentions | umls-concept:C0237881 | lld:lifeskim |
| pubmed-article:9051394 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
| pubmed-article:9051394 | lifeskim:mentions | umls-concept:C1280519 | lld:lifeskim |
| pubmed-article:9051394 | lifeskim:mentions | umls-concept:C0441712 | lld:lifeskim |
| pubmed-article:9051394 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:9051394 | pubmed:dateCreated | 1997-6-26 | lld:pubmed |
| pubmed-article:9051394 | pubmed:abstractText | To examine the significance of alterations in insulin sensitivity index (S(t)), glucose effectiveness (Sg), and beta-cell function in the pathogenesis of type II diabetes in African-Americans with varying degrees of glucose intolerance. | lld:pubmed |
| pubmed-article:9051394 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9051394 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9051394 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9051394 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9051394 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9051394 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9051394 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9051394 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9051394 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9051394 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:9051394 | pubmed:issn | 0149-5992 | lld:pubmed |
| pubmed-article:9051394 | pubmed:author | pubmed-author:GaillardTT | lld:pubmed |
| pubmed-article:9051394 | pubmed:author | pubmed-author:PUIG | lld:pubmed |
| pubmed-article:9051394 | pubmed:author | pubmed-author:SchusterD PDP | lld:pubmed |
| pubmed-article:9051394 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9051394 | pubmed:volume | 20 | lld:pubmed |
| pubmed-article:9051394 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9051394 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9051394 | pubmed:pagination | 396-404 | lld:pubmed |
| pubmed-article:9051394 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:meshHeading | pubmed-meshheading:9051394-... | lld:pubmed |
| pubmed-article:9051394 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9051394 | pubmed:articleTitle | Pathogenetic mechanisms of impaired glucose tolerance and type II diabetes in African-Americans. The significance of insulin secretion, insulin sensitivity, and glucose effectiveness. | lld:pubmed |
| pubmed-article:9051394 | pubmed:affiliation | Department of Medicine, Ohio State University Hospitals, Columbus, USA. | lld:pubmed |
| pubmed-article:9051394 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9051394 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:9051394 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:9051394 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9051394 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9051394 | lld:pubmed |
